Monday, June 02, 2008
Erbitux slightly boosts survival in lung cancer study
CHICAGO - Adding the cancer drug Erbitux to standard chemotherapy helped advanced lung cancer patients live just a month longer than chemo alone, a study found....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment